Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDICOLINE ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 1.1% 1.1%   Bankruptcy risk   4.8% 3.6% 3.4% 3.0% 2.9% 2.7% 12.4% 12.4%   Credit score (0-100)   46 53 54 56 58 60 19 19   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   517 809 752 808 645 696 0.0 0.0   EBITDA   28.8 207 190 185 136 176 0.0 0.0   EBIT   18.4 198 187 185 136 168 0.0 0.0   Pre-tax profit (PTP)   17.8 171.0 144.9 121.8 110.4 139.5 0.0 0.0   Net earnings   13.0 130.6 109.4 92.7 84.6 105.3 0.0 0.0   Pre-tax profit without non-rec. items   17.8 171 145 122 110 140 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   12.4 3.0 0.0 0.0 0.0 65.8 0.0 0.0   Shareholders equity total   441 471 381 373 458 563 483 483   Interest-bearing liabilities   0.0 14.0 77.3 87.2 45.9 23.9 0.0 0.0   Balance sheet total (assets)   717 922 1,020 750 703 932 483 483   Net Debt   -49.0 -116 -94.2 -2.5 -21.5 -125 -483 -483     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   517 809 752 808 645 696 0.0 0.0   Gross profit growth   7.1% 56.6% -7.1% 7.4% -20.2% 7.9% -100.0% 0.0%   Employees   1 1 1 1 1 1 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   717 922 1,020 750 703 932 483 483   Balance sheet change%   3.5% 28.5% 10.7% -26.5% -6.3% 32.6% -48.2% 0.0%   Added value   28.8 206.9 190.0 184.5 135.7 175.6 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -21 -19 -6 0 0 58 -66 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 3.0 4.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   3.6% 24.4% 24.9% 22.9% 21.1% 24.2% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   3.5% 25.4% 19.3% 20.9% 18.7% 20.6% 0.0% 0.0%   ROI %   5.7% 44.9% 39.6% 40.2% 28.1% 30.8% 0.0% 0.0%   ROE %   3.0% 28.6% 25.7% 24.6% 20.3% 20.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   61.4% 51.1% 37.3% 49.8% 65.1% 60.4% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -170.2% -56.0% -49.6% -1.4% -15.8% -71.3% 0.0% 0.0%   Gearing %   0.0% 3.0% 20.3% 23.4% 10.0% 4.2% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 529.7% 92.1% 76.3% 38.0% 81.7% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.7 1.3 0.9 0.8 1.0 0.9 0.0 0.0   Current Ratio   2.4 2.0 1.5 1.9 2.7 2.3 0.0 0.0   Cash and cash equivalent   49.0 129.9 171.5 89.7 67.4 149.0 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   395.9 435.8 348.2 340.9 425.4 497.4 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   29 207 190 185 136 176 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   29 207 190 185 136 176 0 0   EBIT / employee   18 198 187 185 136 168 0 0   Net earnings / employee   13 131 109 93 85 105 0 0